Clinical pharmacy programmatic perspectives on use of direct-acting antivirals for acquired hepatitis C infection in solid organ transplant recipients.
CONCLUSION: Within a solid organ transplantation program, clinical pharmacists and other pharmacy personnel can play vital roles in ensuring safe and effective DAA therapy for recipients of transplanted HCV NAT-positive organs.
PMID: 32537658 [PubMed - as supplied by publisher]
Source: American Journal of Health-System Pharmacy : AJHP - Category: Drugs & Pharmacology Authors: Crona L, Berry H, Byrns J, Campbell U Tags: Am J Health Syst Pharm Source Type: research
More News: Academia | Cardiology | Drugs & Pharmacology | Heart | Heart Transplant | Hepatitis | Hepatitis C | Insurance | Kidney Transplant | Kidney Transplantation | Liver | Liver Transplant | Lung Transplant | Transplant Surgery | Transplants | Urology & Nephrology